Latest Elekta News & Updates

See the latest news and media coverage for Elekta. We track all announcements, press releases, and industry mentions in real time, all in one place.

Elekta

Precision radiotherapy solutions provider

elekta.com

Headquarters: Stockholm, Sweden
Founded year: 1972
Company type: Public company
Number of employees: 4,500–5,000
Industry: Advanced Medical Equipment & Technology

Last updated Today

Latest news about Elekta

In short: Elekta reported improved gross margins, named Jakob Just-Bomholt as CEO, and received FDA clearance for its AI-enhanced Evo system.

Company announcements

September 1 Elekta

Elekta confirms unauthorized access to some customer contact details

The company contained the breach after identifying accessed information as primarily business contact data and notified affected customers regarding mitigation steps.

August 27 Elekta

Elekta improves Q1 profitability and cash generation

Regional results show expansion in the Americas and Europe contrasted with contractions in China and the Asia-Pacific markets.

July 31 Elekta

Elekta notifies shareholders of its Annual General Meeting

The meeting will be held on September 3, 2026, in Stockholm, with proposals on dividend, share buyback, and board elections

July 3 Elekta

Elekta's annual report for 2025/26 is available

The report includes audited statutory annual report, sustainability statement, corporate governance report, and remuneration report.

Media coverage

September 13 Ad hoc news

Elekta stock heads into the open after a 7.3 percent drop

At the close on September 11, 2026, Elekta stock fell 7.3 percent on Nasdaq Stockholm. The shares finished at SEK 47.82, with ...

September 9 Marketscreener

JP Morgan downgrades Coloplast - puts Ambu and Elekta on negative watch list - BN

JP Morgan has downgraded the medical technology company Coloplast to Underweight with a target price of 377 Danish kroner and simultaneously placed Ambu and Elekta on potential...

September 8 Börskollen

Storbanken: Sell the medtech company – points out three major risks

UBS reiterates its sell recommendation for Elekta with a target price of 41 kronor and points to three combined risks that continue to weigh on the company.

September 4 Yahoo Finance

Elekta AB (EKTAF) (Q1 2027) Earnings Call Highlights: Margin Expansion and...

Elekta AB (EKTAF) reports improved gross margins and reaffirms FY '26-'27 guidance despite a 2% sales dip and China weakness.

Never miss news about Elekta

Track Elekta and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Elekta competitors & trending companies

Browse news for competitors to Elekta and other trending companies.